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In the yeast Saccharomyces cerevisiae, the phospholipid biosynthetic genes are highly regulated at the
transcriptional level in response to the phospholipid precursors inositol and choline. In the absence of inositol
and choline (derepressing), the products of the INO2 and INO4 genes form a heteromeric complex which binds
to a 10-bp element, upstream activation sequence INO (UASINO), in the promoters of the phospholipid
biosynthetic genes to activate their transcription. In the presence of inositol and choline (repressing), the
product of the OPI1 gene represses transcription dictated by the UASINO element. Curiously, we identified a
UASINO-like element in the promoters of both the INO2 and INO4 genes. The presence of the UASINO element
in these two promoters suggested that the mechanism for the inositol-choline response would involve regulating expression of the two activator genes. Using a cat reporter gene, we find that INO2-cat expression was
regulated 12-fold in response to inositol and choline but that INO4-cat was constitutively expressed. We further
observed that INO2-cat was not expressed in either an ino2 or an ino4 mutant strain and was constitutively
overexpressed in an opi1 mutant strain. Expression of the INO4-cat gene was affected only by mutation in the
INO4 gene itself. Therefore, INO2-cat transcription is regulated by the products of both the INO2 and INO4
genes whereas INO4 must interact with another protein to activate its own transcription. Our data show that
derepression of phospholipid biosynthetic gene expression involves two mechanisms: increasing the levels of
the INO2 and INO4 gene products and inactivating the OPI1-mediated repression mechanism. We propose a
model suggesting that this dual mechanism of regulation accounts for the observed cooperative stimulation of
INO1 and CHO1 gene expression (phospholipid biosynthetic genes).
The proper function of any cell is dependent on the genetically programmed synthesis of a large number of proteins
expressed at precise levels. Control of transcription initiation
by DNA-binding proteins which recognize positively and negatively acting sequence elements in gene promoters is a primary means of regulating expression (33–35, 41). A further
level of control can be imposed by regulation of the steadystate expression of regulatory genes. This can be accomplished
by a number of different mechanisms. For example, the genes
involved in galactose metabolism in the yeast Saccharomyces
cerevisiae are partially controlled by regulation of transcription
of the GAL4 regulatory gene (13). In this system, a fourfold
transcriptional regulation of the gene encoding the GAL4 activator amplifies to a 170-fold regulation of the GAL1 structural gene. A different mechanism is utilized in control of the
genes for amino acid biosynthesis, in which expression of the
GCN4 activator protein is regulated at the level of translation
(16). A third mechanism for control of expression of activator
genes is by regulation of the decay rate of their messages. For
example, the message for the MATa1 activator gene, which
regulates genes involved in specification of cell type, has a
half-life of 5 min (8). The message for the PPR1 regulatory
gene, which controls transcription of two genes involved in
pyrimidine biosynthesis, has a half-life of 1 min (42). The
stabilities of both of these messages are well under the average
of 17 min for poly(A)1 mRNA in S. cerevisiae. Regardless of

the mechanism, proper control of expression of genes encoding regulatory proteins appears to be important for cells since
overexpression of many activators (including GAL4) is deleterious (11) and even small changes in expression of a regulatory
gene can be amplified to produce large effects on the expression of target genes (13, 48).
In S. cerevisiae, the major membrane phospholipids, phosphatidylinositol (PI) and phosphatidylcholine (PC), are synthesized by two separate pathways that diverge from a common
lipid precursor, CDP-diacylglycerol (CDP-DG) (6, 24). Enzymes in the PI and PC biosynthetic pathways, as well as the
enzyme that synthesizes their common precursor, CDP-DG,
are regulated in a coordinate fashion in response to the phospholipid precursors inositol and choline (4, 7, 9, 18). The coordinate regulation of the genes that encode these enzymes is
accomplished by control of their expression at the level of
transcription through a common set of cis-acting regulatory
elements and their cognate trans-acting factors (37, 52).
Two classes of regulatory genes affecting expression of the
coordinately regulated genes involved in phospholipid biosynthesis have been identified. One class includes the INO2 and
INO4 genes, which encode positive regulators of INO1 expression (17) as well as other phospholipid biosynthetic genes (37).
Recessive mutations in either of these genes reduce expression
of the phospholipid biosynthetic genes to repressed levels (4,
17). Analysis of the sequences of the INO2 and INO4 genes
predicts protein products that include a helix-loop-helix (HLH)
motif (19, 39) which is common to a number of proteins involved in transcriptional regulation (36). These observations
suggest that the products of the INO2 and INO4 genes interact
to activate transcription of the phospholipid biosynthetic
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genes. Consistent with this hypothesis, a protein-DNA complex
that assembles with the INO1 promoter and is dependent on
wild-type alleles of the INO2 and INO4 genes has been identified (31). Recently, Ino2p-specific antibodies were used to
demonstrate that Ino2p is present in this complex (38). In
addition, transcription and translation of both the INO2 and
INO4 genes in vitro have been used to show that both Ino2p
and Ino4p are present in this complex and that they are capable of forming a heterodimer independently of a DNA template (2).
A second class of regulatory mutation is characterized by the
opi1 mutation, which causes a constitutive overexpression of
the INO1 transcript, resulting in an overproduction of inositol
(51). This suggests that the wild-type OPI1 gene product is a
negative regulator of INO1 expression. The OPI1 gene encodes
a protein with a leucine zipper domain. While this domain is
common to transcription-regulatory proteins (22, 26), it is unlikely that Opi1p binds DNA. In our current model, Opi1p
functions by interacting with the Ino2p-Ino4p heterodimer to
inhibit its function. This model is based on evidence showing
that mutations in both INO2 and INO4 are epistatic to OPI1
mutations (30) and that INO2, INO4, and OPI1 functions are
dependent on a common cis-acting element (25). In this respect, OPI1 would function analogously to the product of the
GAL80 gene, which interacts with the GAL4 transcriptional
activator to inhibit its function (23, 27).
The promoters of the coordinately regulated phospholipid
biosynthetic genes contain a common cis-acting regulatory element, upstream activation sequence INO (UASINO), which is
both necessary and sufficient to mediate the inositol-choline
response (25). This element is defined by the consensus sequence 59-C/ATGTGAAAT-39 and serves as the binding site
for the heterodimer formed between the products of the INO2
and INO4 genes (2, 38). The UASINO element is similar to that
reported for the promoters of two fatty acid synthesis genes
(FAS1 and FAS2) which are moderately regulated in response
to inositol and choline (45).
A computer-assisted search of the promoters of the INO2
and INO4 genes revealed that they also contain a single copy of
the UASINO element (see Fig. 1). This led us to investigate
whether expression of these activator genes is also regulated in
response to inositol and choline. We propose a model in which

that the autoregulated transcription of the INO2 and INO4
genes plays a role in cooperative derepression of phospholipid
biosynthetic gene expression.
MATERIALS AND METHODS
Strains and growth conditions. The yeast strains used in this study were
BRS1001 (MATa ade2 his3 leu2 can1 trp1 ura3), a1a (MATa ade2 his3 leu2 ura3
trp1 ino2::TRP1), NUL 20 (MATa ura3 his3 leu2 ino4::LEU2), and BRS1021
(MATa opi1 ade5 leu2 trp1 ura3). All cultures were grown at 308C in synthetic
medium (17) containing 2% glucose (vol/vol) and either containing 75 mM
inositol and 1 mM choline or lacking inositol and choline.
Plasmid construction and chromosomal integration. All plasmids used in this
study were derived from pBM2015 supplied by Mark Johnston (Washington
University, St. Louis, Mo.) (14). This plasmid contained the chloramphenicol
acetyltransferase (CAT) reporter gene (cat) fused to the first eleven codons of
the GAL4 gene, the URA3 yeast selectable marker, and 1.5 to 2.0 kb of DNA
from the region surrounding the GAL4 chromosomal locus. Fusions of the INO2,
INO4, OPI1, and INO1 promoters to the cat reporter were constructed by
amplifying the respective promoters by PCR and subcloning them into a BamHI
site in plasmid pBM2015 upstream of the GAL4-cat fusion. The 39 end of each
promoter is at 21, with 11 being the first nucleotide of the ATG translation start
codon. The 59 ends of the indicated promoters were as follows: INO2, 2506;
INO4, 2495 (Fig. 1); INO1, 2453; and OPI1, 2439. The promoter-cat fusions
were integrated at the GAL4 chromosomal locus by transformation of yeast with
the products of a restriction digestion that releases a 7.6-kb fusion construct from
the vector (Fig. 2). Since the ends of DNA fragments are highly recombinogenic
(40), URA1 transformants arise by recombination between sequences flanking
GAL4. Southern blot analysis confirmed proper integration of the fusions in all
transformants tested.
Enzyme assays. For CAT assays, 5-ml cultures were grown to 50 to 60 Klett
units in synthetic medium containing or lacking inositol and choline. Cells were
pelleted, washed with 0.5 ml of 0.25 M Tris-HCl (pH 7.5), and resuspended in 0.2
ml of ice-cold 0.25 M Tris-HCl (pH 7.5). Acid-washed glass beads were added to
a level 1 to 2 mm below the meniscus, and the cells were shaken at maximum
speed on a Vortex at 48C for eight 20-s periods, with 20-s pauses between each
period. Cellular debris were pelleted in a microcentrifuge at 48C for 5 min, and
cell extracts were stored at 2708C. The protein concentration in each extract was
determined with a Bio-Rad protein assay kit (Bio-Rad, Rockville Center, N.Y.),
and CAT activities were determined by the phase extraction method (43). Generally, 10 mg of protein was assayed in a 100-ml reaction volume. Units of CAT
activity are defined as counts per minute measured in the organic phase and
expressed as a percentage of total counts per minute (percent conversion) divided by the amount of protein assayed (in micrograms) and the time of incubation (in hours).
RNA analysis. RNA was isolated from yeast by a glass bead disruption and hot
phenol extraction procedure (10). RNA probes (cRNA) for Northern (RNA)
hybridizations were synthesized with the Gemini II Core System (Promega) from
plasmids linearized with a restriction enzyme and transcribed with an RNA
polymerase as follows (shown as plasmid, restriction enzyme, RNA polymerase)
for the indicated (parenthesized) probe: pAB309D, EcoRI, SP6 (TCM1);
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FIG. 1. INO2 and INO4 promoter sequences. Noted for reference are the initiation codons (MET), potential UASINO elements (arrows indicate orientations), a
potential TATA box in the INO4 promoter (underlined), and the oligonucleotide primers (with flanking restriction sites) used for PCR amplification.
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TABLE 1. Regulation of INO2-cat gene expression
Reporter genea

CAT activity (U)b in:
I2C2d

I1C1e

0.75
4.41
18.50
33.90
0.01

0.08
4.37
11.00
1.30
0.01

INO2-cat
INO4-cat
OPI1-cat
INO1-cat
Promoterless-cat

Fold differencec

12.3 (2.8)
1.0 (0.1)
1.7 (0.2)
27.0 (9.6)
1.1 (0.6)

FIG. 2. Integration of INO2- and INO4-cat fusions in a single copy at the
GAL4 locus of S. cerevisiae. DNA fragments (approximately 500 bp) containing
the INO2 or the INO4 promoter flanked by BamHI-BglII sites were inserted into
the BamHI site of pBM2015 (14). A 7.6-kb SstI-KpnI restriction fragment was
used to transform a uracil auxotrophic yeast strain, yielding stable single-copy
integrants. Shown for reference are sequences that include the GAL4 locus
(hatched box), the direction of transcription (arrows), and the locations of the
URA3 and cat genes.

pJH310, HindIII, T7 (INO1); pAS103, HindIII, T7 (CHO1) (20). Northern hybridizations were performed as previously described (17), and results were visualized by autoradiography and quantitated by densitometry.
Derepression assay. To determine the kinetics of derepression of the INO2
and INO1 genes, wild-type strains harboring either an INO2-cat reporter fusion
or an INO1-cat reporter fusion were inoculated into 20 ml of medium supplemented with inositol and choline (repressing). Cultures were grown to mid-log
phase (50 to 60 Klett units), and cells were collected by filtration onto a nitrocellulose filter with a Millipore filter apparatus. Cells were washed twice with
prewarmed medium lacking inositol and choline and then resuspended in 25 ml
of medium lacking inositol and choline (derepressing). Samples (5 ml) were
taken at various times (see the text) and assayed for CAT activity as described
earlier.

RESULTS
INO2-cat, but not INO4-cat, expression is regulated by inositol and choline. To determine if INO2 and/or INO4 are
regulated in response to inositol and choline, we constructed
plasmids that fused sequences upstream of the ATG translation start codons of the INO2 and INO4 genes to a GAL4-cat
fusion reporter gene. A single copy of these fusions was integrated into the yeast genome without any associated vector
sequences by recombination at the GAL4 locus (Fig. 2). We
chose this assay because we suspected that expression of INO2
and INO4 would be low since genes encoding activators generally tend to be weakly expressed (14, 42). The data in Table
1 show that expression of the INO2-cat reporter gene was
approximately 12-fold higher in the absence of inositol and
choline than in their presence. In contrast, there was no difference in the level of expression of the INO4-cat fusion in the
presence or absence of inositol and choline. As a control, a
promoterless cat construct was also analyzed and the results
show that there was no cat expression from this vector (Table
1). Therefore, any expression observed in this system must

originate from the inserted promoters. In addition, the INO4cat construct was expressed at a level sixfold higher than was
the INO2-cat construct under derepressing conditions, which
suggests that INO2 expression is limiting relative to that of
INO4.
Interestingly, the pattern of INO2-cat expression is reminiscent of the pattern of expression of one of its target genes,
INO1 (17). This point was illustrated by analysis of INO1-cat
expression (Table 1). The results agree with published data
describing INO1 regulation (17) and show that INO2-cat was
expressed at a level roughly 45-fold less than was INO1-cat.
INO2-cat and INO4-cat expression is autoregulated. To determine if INO2 and INO4 expression is autoregulated, the
INO2-cat and INO4-cat reporter constructs were transformed
into both ino2 and ino4 null mutant strains. Strains harboring
the fusion constructs were assayed for CAT activity under
repressing conditions (75 mM inositol and 1 mM choline). The
data show that INO2-cat was not expressed in either the ino2 or
ino4 mutant strain (Table 2). It should be noted that the
expression of the INO2-cat construct at this concentration of
inositol was reduced to a level equal to that of a promoterless

TABLE 2. Autoregulation of INO2-cat and INO4-cat
gene expression
CAT activity (U)c in medium with:

Relevant
strain
genotypeb

10 mM inositol,
1 mM choline

75 mM inositol,
1 mM choline

INO2-cat
INO2-cat
INO2-cat

Wild type
ino2
ino4

0.43
0.02
0.01

0.08
0.02
0.02

INO4-cat
INO4-cat
INO4-cat

Wild type
ino2
ino4

NDd
3.35
0.01

4.37
4.20
0.02

Promoterless-cat
Promoterless-cat

ino2
ino4

0.02
0.02

0.02
0.02

a

Reporter gene

a
Each reporter gene was integrated in single copy at the GAL4 locus as
described in Materials and Methods.
b
The strains used in these experiments were BRS1001 (wild type), a1A (ino2),
and NUL20 (ino4).
c
Assays were carried out with extracts from yeast transformants harboring
each of the reporter genes. Each value is the average of data from at least three
experiments.
d
ND, not determined.
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a
Each reporter gene was integrated in a single copy at the GAL4 locus of
BRS1001 as described in Materials and Methods.
b
Assays were carried out with extracts from yeast transformants harboring
each of the reporter genes. Each value is the average of data from at least four
experiments.
c
Average of the fold differences (I2C2/I1C1) for each experiment, with
standard deviation in parentheses.
d
I2C2, complete synthetic medium (17) lacking inositol and choline.
e
I1C1, complete synthetic medium (17) supplemented with 75 mM inositol
and 1 mM choline.
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TABLE 3. Regulation of INO2-cat expression by the OPI1 gene
CAT activity (U)c in:
I2C2d

I1C1e

INO2-cat
INO2-cat

Wild type
opi1 INO2 INO4

0.75
4.00

0.08
5.23

INO4-cat
INO4-cat

Wild type
opi1 INO2 INO4

4.41
4.36

4.37
5.85

Promoterless-cat
Promoterless-cat

Wild type
opi1 INO2 INO4

0.01
0.02

0.01
0.02

a
Each reporter gene was integrated in a single copy at the GAL4 locus as
described in Materials and Methods.
b
The strains used in these experiments were BRS1001 (wild type) and
BRS1021 (opi1 INO2 INO4).
c
Assays were carried out with extracts from yeast transformants harboring
each of the reporter genes. Each value is the average of data from at least three
experiments.
d
I2C2, complete synthetic medium (17) lacking inositol and choline.
e
I1C1, complete synthetic medium (17) supplemented with 75 mM inositol
and 1 mM choline.

cat construct. Further, the repressed level of expression of
INO2-cat in the ino2 and ino4 mutant strains was about fourfold lower than the repressed level in the wild-type strain
(Table 2). The INO2-cat strains were also grown in medium
containing 10 mM inositol to test the effects of the ino2 and
ino4 mutations under derepressing conditions. This concentration of inositol is the minimal amount required for growth of
the ino2 and ino4 strains while simultaneously allowing partial
derepression of gene expression. While in the wild-type strain
an intermediate level of expression of INO2-cat was observed
(Table 2), INO2-cat was not expressed in either the ino2 or
ino4 mutant strains at this concentration (Table 2). These
results suggest that wild-type alleles of both the INO2 and
INO4 genes are required for expression of the INO2 gene.
In contrast to INO2-cat expression, INO4-cat was expressed
at wild-type levels in the ino2 mutant strain both at 10 mM
inositol and at 75 mM inositol (Table 2). However, INO4-cat
expression was abolished in the ino4 mutant strain (Table 2).
This suggests that the constitutive expression of INO4 requires
a wild-type copy of the INO4 gene but does not require the
INO2 gene.
The INO2-cat gene is overexpressed in an opi1 mutant
strain. Regulation of expression of the phospholipid biosynthetic genes is also controlled by a negative regulator, encoded
by the OPI1 gene (51), and its action is dependent upon the
UASINO element. Strains harboring mutant alleles of the OPI1
gene constitutively overexpress the phospholipid biosynthetic
genes (4, 17). To determine if INO2 and INO4 expression is
also negatively regulated by OPI1, the INO2-cat and INO4-cat
fusion constructs were used to transform an opi1 mutant strain.
The data show that in the opi1 strain INO2-cat was overexpressed constitutively at a level higher than the fully derepressed level in the wild-type strain (Table 3). Curiously,
INO2-cat expression in this strain was equivalent to that of
INO4-cat in the wild-type strain. In contrast, INO4-cat expression was unaffected by this mutation. Therefore, INO2, but not
INO4, expression is negatively regulated by the product of the
OPI1 gene.
OPI1-cat gene expression is modestly regulated and nonlimiting. Since the OPI1 negative regulatory gene was required for
the inositol-choline response, we reasoned that its expression
may also be regulated. This type of mechanism has already
been reported for the GAL80 gene of S. cerevisiae (21, 46).

FIG. 3. Northern blot hybridization of phospholipid biosynthetic genes. A
representative Northern blot hybridization showing INO1 and CHO1 transcript
levels in cells grown in complete synthetic media supplemented with various
inositol concentrations (0 to 100 mM) is displayed. The constitutively expressed
ribosomal protein gene TCM1 (32) was used to normalize for loading variations.

Therefore, we determined the level of expression from the
OPI1 promoter using the cat reporter system. The data show
that there was a modest regulation of OPI1-cat expression
(1.7-fold; Table 1). However, the more significant observation
was that OPI1-cat expression was always in large excess relative
to INO2-cat and INO4-cat expression. This suggests that the
inositol-choline response may be initiated by the product of the
OPI1 gene.
Cooperative regulation of the phospholipid biosynthetic
genes by INO2. Since INO2-cat expression was regulated and
the target genes have multiple INO2-binding sites, we examined whether there is cooperativity in regulation of phospholipid biosynthetic gene expression. To do this, we quantitated
expression of two INO2 target genes under growth conditions
that establish different levels of INO2 expression. The two
target genes were INO1 and CHO1, which have two and one
binding site(s), respectively.
To establish different levels of INO2 expression, cells were
grown in media supplemented with different concentrations of
inositol (range, 0 to 100 mM). The amount of INO2 expression
was determined by assay of CAT activity in a wild-type strain
harboring the INO2-cat reporter fusion, whereas INO1, CHO1,
and TCM1 expression was determined by Northern blot hybridization. A representative Northern blot hybridization
showing the patterns of expression and the specificity of the
probes is shown (Fig. 3). The constitutively expressed ribosomal protein gene TCM1 was used to normalize for loading
variations. The patterns of expression of INO1 and CHO1
relative to INO2-cat were best fit by a sigmoidal curve (Fig. 4).
In support of this observation, the Hill coefficients were determined to be 3.04 and 1.42 for the INO1 and CHO1 curves,
respectively (EnzFit version 1.05; Elsevier-Biosoft). This sigmoidal relation was characteristic of a cooperative mechanism
(12, 13), which was surprising since the CHO1 promoter only
has a single UASINO element (3). Even the INO1 cooperativity
cannot be explained on the basis of multiple UASINO elements
since there was no synergism between the two INO1 UASINO
elements (25, 31). A model to explain this cooperativity will be
discussed in detail later.
Kinetics of INO2 and INO1 derepression. Regulation of
INO2-cat expression is reminiscent of that of its target genes.
For example, the expression of both INO2-cat and INO1-cat
was regulated (Table 1), sensitive to ino2 and ino4 mutant
alleles (Table 2) (17), and regulated by the OPI1 repressor
(Table 3) (17). Since INO2 is required for its own expression as
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well as expression of the INO1 gene, the kinetics of INO2 and
INO1 derepression might be different for these two genes.
Strains harboring either an INO1-cat fusion or an INO2-cat
fusion were used to determine the kinetics of derepression.
Cultures were grown in medium supplemented with inositol
and choline (repressing) and were then switched to medium
lacking inositol and choline (derepressing). Samples were
taken at various time points after the switch to derepressing
medium and assayed for CAT activity. The data show that the
pattern of INO2-cat derepression was similar to that of INO1cat; however, INO2-cat expression is moderately higher than
INO1-cat expression at an earlier time point (Fig. 5). Both
genes were fully derepressed at 2.5 h.
Relative promoter strengths. Our analysis of INO2-cat and
INO4-cat expression suggests that the promoters of these two
genes are extremely weak. To examine this, we compared fully
derepressed expression from several yeast promoters using cat
fusions (data not shown). The experiments revealed that the
GAL4 promoter (previously the weakest known promoter) was
about 2.1-fold stronger than the INO2 promoter while the

FIG. 5. Comparison of derepression kinetics of INO1-cat and INO2-cat expression. Strains harboring an INO2-cat fusion or an INO1-cat fusion were grown
to mid-log phase in repressing medium (containing inositol and choline) and
switched to derepressing medium (containing neither inositol nor choline). Samples were taken at various time points and assayed for CAT activity.

INO4 promoter was slightly stronger than the GAL4 promoter
(2.8-fold). The OPI1 and the INO1 promoters were substantially stronger than the INO2 promoter (24.7- and 45.2-fold,
respectively).
DISCUSSION
Regulation of phospholipid biosynthesis is dictated by the
UASINO element, which serves as a binding site for Ino2-Ino4
heterodimer (2, 25, 34). Here, we report that expression of an
INO2-cat reporter gene was found to be controlled by this
same regulatory scheme (autoregulation) while an INO4-cat
gene was expressed constitutively (Table 1). The regulated
expression of the INO2-cat gene suggests that regulation of
INO2 transcript abundance may be an important mechanism
for control of phospholipid biosynthetic gene expression. However, a caveat that should be noted is that we have not determined if the levels of Ino2 protein reflect the regulation observed from the INO2-cat reporter gene.
Expression of the INO2-cat gene was regulated 12-fold in
response to inositol and choline, but even under derepressing
conditions its expression was limiting relative to expression of
the INO4-cat genes. Interestingly, in the opi1 mutant strain
INO2-cat was constitutively overexpressed and its expression
was equal to that of the INO4-cat gene in a wild-type strain
(Table 3). This suggests that INO4 expression may act as a
backstop to ensure that INO2 expression does not exceed that
of INO4. Furthermore, the overexpression of the INO2-cat
gene explains why phospholipid biosynthetic genes are constitutively overexpressed in an opi1 mutant strain (4, 17).
Our finding that the INO4-cat gene was expressed constitutively disagrees with preexisting data (45) which showed that
INO4-lacZ expression was repressed twofold in response to
inositol and choline. However, the level of INO4-lacZ expression was actually below the limits of sensitivity for the assay
and was compared with that of an entirely different control
vector. In the present report, the level of INO4-cat expression
was substantially above the lower limits of sensitivity for this
system. Moreover, our experiments examined INO4 promoter
activity in a native context (chromosomal) and in a single copy,
thus avoiding any potential multicopy or plasmid-related artifacts. We have also determined that the native INO4 mRNA is
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FIG. 4. Effects of variation in levels of INO2 expression on INO1 (A) and CHO1 (B) expression. INO2 expression was determined by assay of INO2-cat activity.
INO1 and CHO1 expression was determined by Northern blot hybridization. The extent of hybridization was quantitated by densitometry (arbitrary units), normalized
for loading variations with the constitutively expressed ribosomal protein gene TCM1 (32). All assays were performed with cultures growing exponentially in complete
synthetic medium (17) containing 1 mM choline and either lacking inositol or containing 10, 17.5, 25, 50, 75, or 100 mM inositol.
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FIG. 6. Model for cooperative derepression of phospholipid biosynthetic
gene expression in S. cerevisiae. See Discussion for a detailed explanation. I1C1,
containing inositol and choline; I2C2, containing neither inositol nor choline.

and inactivation of the Opi1 repressor protein. This model
predicts that Opi1 provides the initial response; however, it
cannot predict the nature of the interaction between the repressor and the two activators. Several additional observations
support this model. The OPI1-cat gene is overexpressed relative to both INO2-cat and INO4-cat, and its expression is essentially unaffected by inositol and choline (Table 1). Furthermore, it has already been reported that the amount of Ino2Ino4–UASINO complex is affected by inositol and choline (31).
Therefore, the model predicts that OPI1 is required for the
initial response to inositol and choline but that regulation of
INO2 expression establishes the magnitude and cooperativity
of the response.
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constitutively expressed (2a), using a reverse transcriptionPCR protocol (50).
Expression of the INO2-cat gene was weak relative to the
expression of several other yeast genes, including GAL4. Previously, the GAL4 regulatory gene was recognized as the weakest promoter in yeast (13). The low level of GAL4 transcription
is established by two elements, UASGAL4 and UESGAL4 (UES
stands for upstream essential sequence), which can only function together (14). That is, UASGAL4 is not able to function in
concert with a canonical TATA element and UESGAL4 is not
able to function with a heterologous UAS element (14). However, the mechanism that establishes weak expression of INO2
must be different, since the INO2 promoter does contain a
UASINO element which is sufficient to confer inositol- and
choline-dependent expression from a heterologous TATA element (25). A computer-assisted search of the INO2 promoter
failed to identify an element resembling a TATA box. Therefore, it is likely that a poor TATA-element and/or a weak
transcription initiation site (15, 49) may be responsible for the
weak expression of the INO2 gene.
Expression of the INO4-cat gene was dependent on a wildtype allele of the INO4 gene but not the INO2 gene (Table 2).
Since the Ino4 protein does not appear to have any transcriptional activation domain (2a) and does not homodimerize (2),
it must form a heterodimer with another protein that has a
transcriptional activation domain. In support, it is not unprecedented for HLH proteins to form dimers with multiple partners. For example, the mammalian protein Max can form homodimers or heterodimers with Myc, Mad, and Mxi (1). We
have already determined that the other three known yeast
transcriptional activator HLH proteins, Pho4 (44), Cbf1 (5),
and Rtg1 (29), are not required for INO4 expression. Consequently, there must be another as-yet-unidentified partner for
the INO4 gene. Another issue that must be addressed is that of
the function of the UASINO element in the INO4 promoter.
Conceivably, single-base changes from the UASINO element
consensus may dictate specificity for different sets of partners.
This has been shown to be the case for mammalian HLH
proteins in which base changes in a Myc/Max-binding site will
create a Max/Max-binding site (47). Interestingly, the yeast
CTR1 gene also requires INO4 but not INO2 for its expression
(28). A comparison of the CTR1 and INO4 promoters identified a consensus HLH binding site (CAA/TTG) that deviates
from the UASINO element.
The data showed that cooperativity plays a role in control of
expression of INO1 and CHO1 (Fig. 4). This is not unprecendented in S. cerevisiae, since cooperativity was also invoked in
GAL4 activation of GAL1 expression (12, 13). A similar mechanism could exist for activation of the INO1 gene, since there
are two UASINO elements in this promoter (25). However,
there is no evidence of synergism between these elements or
cooperativity of binding to these two sites (25, 31). We therefore propose an alternative model to explain the cooperative
derepression of INO1 and CHO1 expression (Fig. 6). When
cells are grown in medium containing inositol and choline
(repressing), two mechanisms exist for repression of phospholipid biosynthetic gene expression. The Opi1 repressor interacts with the Ino2-Ino4 heterodimer to decrease expression of
the INO2, INO1, and CHO1 genes and reduce the amount of
Ino2-Ino4 heterodimer available to bind the UASINO element.
The mechanism for derepression requires that the repressing
action of the Opi1 protein be inactivated, allowing the phospholipid biosynthetic genes as well as the INO2 activator gene
to be derepressed and resulting in complete derepression of
these genes. Therefore, cooperativity in this system results
from the concomitant derepression of the INO2 activator gene
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